Arkolith/Insider Trading/ORKA/Form 4

Sandler Laura Lee

Chief Operating OfficerOruka Therapeutics, Inc. (ORKA) · full profile →Form 4 · filed Jul 1, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$472K
Net Open-Market Flow
-$472K
Transactions
5
4 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 1, 2026Option exercise(M)5K$7.80$39K241K
Jul 1, 2026Sell(S)2K$93.85$210K239K
Jul 1, 2026Sell(S)2K$94.75$214K237K
Jul 1, 2026Sell(S)500$95.47$48K236K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jul 1, 2026Option exercise(M)5K—$080K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000907654-26-000069) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML